首页> 外国专利> METHOD OF CONTROL OF BIOGEL CYTOTOXICITY USING HUMAN TRANSPLANTABLE LEUKOCYTE STRAIN L-41-KL/84

METHOD OF CONTROL OF BIOGEL CYTOTOXICITY USING HUMAN TRANSPLANTABLE LEUKOCYTE STRAIN L-41-KL/84

机译:人可移植白细胞株L-41-KL / 84控制生物凝胶细胞毒性的方法

摘要

FIELD: medicine, experimental virology, plastic surgery. SUBSTANCE: invention relates to method of evaluation of quality of polyacrylamide gels. Control of biogel cytotoxicity is carried out using the strain L-41-KL/84 of human transplantable leukocytes. Gel is added to medium of test-culture growth at the dose of cells 60 000 cells/ml and cultured for 72-96 h followed by assay of cytophysiological and cytomorphological stability of culture in dynamics. Morphological study is carried out by conventional procedure. Indices of attachment efficiency, proliferative and mitotic activity of cells, mitosis pathology and morphology of cells in culture are determined. Cytotoxicity of biogels is estimated by change of these indices as compared with control data. The same test-culture is used as control but without gel addition. Invention ensures to differentiate biogel preparations by their cytotoxicity that excludes the possibility of using cytotoxic and adulterated materials and prevents deleterious results of effect on body. Objectivity and standard of control of preparation quality provides the use of standard test-culture of human transplantable leukocytes of the strain L-41-KL/84 for evaluation of cytotoxicity being this strain shows stability of cultural and morphological traits. Morphological analysis ensures to evaluate the trend of cytotoxic effect of analyzed gel in determination of changes of mitotic activity, morphology, in part, the state of metaphase nuclei in cellular culture. EFFECT: improved method of control. 2 cl, 1 tbl
机译:领域:医学,实验病毒学,整形外科。用于评估聚丙烯酰胺凝胶质量的方法本发明涉及一种用于评估聚丙烯酰胺凝胶质量的方法。使用人可移植白细胞的L-41-KL / 84菌株来控制生物凝胶的细胞毒性。将凝胶以细胞60 000个细胞/ ml的剂量添加到测试培养物生长的培养基中,并培养72-96小时,然后动态测定培养物的细胞生理学和细胞形态学稳定性。形态学研究通过常规方法进行。确定培养中细胞的附着效率,细胞的增殖和有丝分裂活性,细胞的有丝分裂病理学和形态的指标。通过与对照数据相比这些指数的变化来估计生物凝胶的细胞毒性。相同的测试培养物用作对照,但不添加凝胶。本发明确保通过其细胞毒性来区分生物凝胶制剂,这排除了使用细胞毒性和掺假物质的可能性,并防止了对人体的有害影响。制备质量的客观性和控制标准提供了使用L-41-KL / 84菌株的人类可移植白细胞的标准测试培养物来评估细胞毒性的方法,因为该菌株显示出稳定的培养和形态特征。形态学分析可确保评估被分析凝胶的细胞毒性作用趋势,以确定有丝分裂活性,形态,部分确定细胞培养中期核状态的变化。效果:改进的控制方法。 2厘升,1汤匙

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号